| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.695 | 0.009 | 0.838 | Aryl hydrocarbon receptor agonist | 0.838 0.005 CID_108113 | CID_108113 | |
| 0.638 | 0.031 | 0.638 | Caspase 9 stimulant | 0.455 0.08 CID_108113 | ||
| 0.604 | 0.004 | 0.604 | Mcl-1 antagonist | 0.48 0.006 CID_108113 | ||
| 0.521 | 0.011 | 0.521 | Superoxide dismutase inhibitor | 0.474 0.015 CID_108113 | ||
| 0.515 | 0.008 | 0.515 | Sigma receptor agonist | 0.446 0.015 CID_108113 | ||
| 0.523 | 0.024 | 0.523 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.448 0.063 CID_108113 | ||
| 0.553 | 0.06 | 0.553 | Apoptosis agonist | 0.462 0.087 CID_108113 | ||
| 0.518 | 0.026 | 0.518 | Thioredoxin glutathione reductase inhibitor | 0.375 0.066 CID_108113 | ||
| 0.495 | 0.005 | 0.495 | DNA intercalator | 0.334 0.01 CID_108113 | ||
| 0.494 | 0.03 | 0.512 | Calcium channel L-type activator | 0.512 0.023 CID_108113 | CID_108113 | |
| 0.481 | 0.022 | 0.525 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.525 0.017 CID_108113 | CID_108113 | |
| 0.463 | 0.009 | 0.463 | Calcium channel activator | 0.439 0.013 CID_108113 | ||
| 0.473 | 0.032 | 0.473 | Streptokinase A inhibitor | 0.353 0.061 CID_108113 | ||
| 0.472 | 0.032 | 0.472 | Calpain 2 inhibitor | 0.398 0.062 CID_108113 | ||
| 0.467 | 0.036 | 0.487 | GABA C receptor rho-3 antagonist | 0.487 0.029 CID_108113 | CID_108113 | |
| 0.464 | 0.036 | 0.464 | Vasodilator, peripheral | 0.343 0.077 CID_108113 | ||
| 0.428 | 0.02 | 0.584 | Interleukin 2 agonist | 0.584 0.004 CID_108113 | CID_108113 | |
| 0.427 | 0.023 | 0.43 | DNA damaging | 0.43 0.022 CID_108113 | CID_108113 | |
| 0.404 | 0.007 | 0.521 | Interleukin 6 antagonist | 0.521 0.004 CID_108113 | CID_108113 | |
| 0.423 | 0.06 | 0.452 | Prostaglandin dehydrogenase inhibitor | 0.452 0.053 CID_108113 | CID_108113 | |
| 0.418 | 0.066 | 0.418 | Histamine release inhibitor | 0.349 0.1 CID_108113 | ||
| 0.353 | 0.006 | 0.396 | Toll-Like receptor 9 antagonist | 0.396 0.005 CID_108113 | CID_108113 | |
| 0.386 | 0.04 | 0.386 | Vasodilator, coronary | 0.375 0.044 CID_108113 | ||
| 0.387 | 0.043 | 0.387 | 12-Lipoxygenase inhibitor | 0.376 0.047 CID_108113 | ||
| 0.369 | 0.029 | 0.369 | Vasodilator | 0.285 0.054 CID_108113 | ||
| 0.34 | 0.004 | 0.34 | Mannose-6-phosphate isomerase inhibitor | 0.288 0.006 CID_108113 | ||
| 0.342 | 0.008 | 0.342 | M18 aspartyl aminopeptidase inhibitor | 0.255 0.02 CID_108113 | ||
| 0.33 | 0.008 | 0.33 | Glutamate receptor antagonist | 0.28 0.012 CID_108113 | ||
| 0.346 | 0.029 | 0.385 | Peroxidase inhibitor | 0.385 0.023 CID_108113 | CID_108113 | |
| 0.323 | 0.01 | 0.354 | Histone acetyltransferase inhibitor | 0.354 0.007 CID_108113 | CID_108113 | |
| 0.319 | 0.009 | 0.319 | UDP-glucose 4-epimerase inhibitor | 0.203 0.018 CID_108113 | ||
| 0.413 | 0.104 | 0.413 | Transcription factor inhibitor | 0.351 0.13 CID_108113 | ||
| 0.306 | 0.01 | 0.306 | 3C-like protease (Human coronavirus) inhibitor | 0.255 0.025 CID_108113 | ||
| 0.306 | 0.01 | 0.306 | Succinate dehydrogenase inhibitor | 0.244 0.024 CID_108113 | ||
| 0.33 | 0.04 | 0.413 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.413 0.023 CID_108113 | CID_108113 | |
| 0.299 | 0.012 | 0.299 | Nitric-oxide synthase stimulant | 0.28 0.017 CID_108113 | ||
| 0.291 | 0.004 | 0.291 | Sphingosine 1-phosphate receptor 4 antagonist | 0.207 0.008 CID_108113 | ||
| 0.308 | 0.021 | 0.308 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.296 0.025 CID_108113 | ||
| 0.29 | 0.007 | 0.29 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.194 0.017 CID_108113 | ||
| 0.399 | 0.12 | 0.399 | DNA polymerase beta inhibitor | 0.36 0.135 CID_108113 | ||
| 0.285 | 0.006 | 0.285 | Porphobilinogen synthase inhibitor | 0.184 0.014 CID_108113 | ||
| 0.305 | 0.028 | 0.305 | Dual specificity phosphatase 3 inhibitor | 0.179 0.074 CID_108113 | ||
| 0.287 | 0.012 | 0.287 | Hexokinase inhibitor | 0.27 0.014 CID_108113 | ||
| 0.279 | 0.005 | 0.279 | Triose-phosphate isomerase inhibitor | 0.176 0.014 CID_108113 | ||
| 0.289 | 0.016 | 0.359 | Heat shock protein 90 alpha antagonist | 0.359 0.008 CID_108113 | CID_108113 | |
| 0.313 | 0.042 | 0.379 | Interleukin agonist | 0.379 0.022 CID_108113 | CID_108113 | |
| 0.274 | 0.005 | 0.274 | Alcohol oxidase inhibitor | 0.164 0.009 CID_108113 | ||
| 0.315 | 0.046 | 0.315 | Transcription factor STAT3 inhibitor | 0.275 0.067 CID_108113 | ||
| 0.315 | 0.047 | 0.394 | Dyrk kinase inhibitor | 0.394 0.027 CID_108113 | CID_108113 | |
| 0.313 | 0.049 | 0.313 | Transcription factor STAT inhibitor | 0.272 0.072 CID_108113 | ||
| 0.278 | 0.014 | 0.308 | Interleukin 1 antagonist | 0.308 0.01 CID_108113 | CID_108113 | |
| 0.298 | 0.034 | 0.298 | Tyrosine 3 hydroxylase inhibitor | 0.255 0.064 CID_108113 | ||
| 0.384 | 0.122 | 0.384 | DNA directed DNA polymerase inhibitor | 0.371 0.129 CID_108113 | ||
| 0.284 | 0.032 | 0.284 | DNA methyltransferase I inhibitor | 0.251 0.046 CID_108113 | ||
| 0.294 | 0.044 | 0.294 | Cyclic AMP phosphodiesterase inhibitor | 0.219 0.081 CID_108113 | ||
| 0.261 | 0.011 | 0.276 | Interleukin 1b antagonist | 0.276 0.01 CID_108113 | CID_108113 | |
| 0.288 | 0.038 | 0.288 | 5 Hydroxytryptamine 1E antagonist | 0.271 0.053 CID_108113 | ||
| 0.355 | 0.111 | 0.355 | 5 Hydroxytryptamine release inhibitor | 0.265 0.208 CID_108113 | ||
| 0.258 | 0.016 | 0.293 | Alkylator | 0.293 0.013 CID_108113 | CID_108113 | |
| 0.245 | 0.004 | 0.318 | CD45 antagonist | 0.318 0.004 CID_108113 | CID_108113 | |
| 0.272 | 0.033 | 0.272 | Dual specificity phosphatase inhibitor | 0.151 0.093 CID_108113 | ||
| 0.252 | 0.022 | 0.252 | Alpha-N-acetylglucosaminidase inhibitor | 0.153 0.053 CID_108113 | ||
| 0.338 | 0.109 | 0.369 | Antibacterial | 0.369 0.091 CID_108113 | CID_108113 | |
| 0.245 | 0.017 | 0.274 | Toll-Like receptor antagonist | 0.274 0.01 CID_108113 | CID_108113 | |
| 0.238 | 0.01 | 0.284 | NMDA receptor antagonist | 0.284 0.007 CID_108113 | CID_108113 | |
| 0.238 | 0.011 | 0.238 | Adenylate kinase inhibitor | 0.217 0.013 CID_108113 | ||
| 0.237 | 0.009 | 0.237 | Calcium antagonist | 0.138 0.027 CID_108113 | ||
| 0.248 | 0.021 | 0.301 | Heat shock protein 90 antagonist | 0.301 0.01 CID_108113 | CID_108113 | |
| 0.279 | 0.053 | 0.279 | Pyruvate kinase inhibitor | 0.19 0.087 CID_108113 | ||
| 0.254 | 0.031 | 0.254 | Amyloid beta precursor protein antagonist | 0.211 0.051 CID_108113 | ||
| 0.27 | 0.048 | 0.27 | Calpain inhibitor | 0.257 0.058 CID_108113 | ||
| 0.227 | 0.007 | 0.24 | HIV-1 integrase (Overall Integration) inhibitor | 0.24 0.005 CID_108113 | CID_108113 | |
| 0.352 | 0.135 | 0.352 | Alpha-glucosidase inhibitor | 0.265 0.178 CID_108113 | ||
| 0.217 | 0.008 | 0.217 | Creatine kinase inhibitor | 0.158 0.021 CID_108113 | ||
| 0.24 | 0.032 | 0.24 | Cytidine deaminase inhibitor | 0.153 0.073 CID_108113 | ||
| 0.223 | 0.018 | 0.223 | Ferrochelatase inhibitor | 0.151 0.037 CID_108113 | ||
| 0.252 | 0.047 | 0.252 | DNA methylase inhibitor | 0.221 0.066 CID_108113 | ||
| 0.207 | 0.005 | 0.207 | Biliverdin reductase inhibitor | 0.178 0.007 CID_108113 | ||
| 0.277 | 0.078 | 0.277 | Hypoxia-inducible factor 1 alpha inhibitor | 0.211 0.139 CID_108113 | ||
| 0.205 | 0.006 | 0.205 | DOPA decarboxylase inhibitor | 0.188 0.009 CID_108113 | ||
| 0.219 | 0.021 | 0.219 | Catenin beta inhibitor | 0.191 0.04 CID_108113 | ||
| 0.2 | 0.003 | 0.2 | Kainate receptor 5 antagonist | 0.074 0.004 CID_108113 | ||
| 0.203 | 0.009 | 0.226 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.226 0.007 CID_108113 | CID_108113 | |
| 0.22 | 0.027 | 0.22 | M17 leucyl aminopeptidase inhibitor | 0.157 0.051 CID_108113 | ||
| 0.225 | 0.032 | 0.225 | 5 Hydroxytryptamine 3E antagonist | 0.195 0.071 CID_108113 | ||
| 0.24 | 0.047 | 0.24 | Non-steroidal antiinflammatory agent | 0.189 0.08 CID_108113 | ||
| 0.198 | 0.009 | 0.198 | Thioredoxin inhibitor | 0.149 0.017 CID_108113 | ||
| 0.202 | 0.012 | 0.202 | Alcohol dehydrogenase inhibitor | 0.151 0.02 CID_108113 | ||
| 0.223 | 0.035 | 0.223 | Glycogen synthase kinase-3 alpha inhibitor | 0.184 0.046 CID_108113 | ||
| 0.206 | 0.018 | 0.206 | CF transmembrane conductance regulator agonist | 0.194 0.025 CID_108113 | ||
| 0.204 | 0.017 | 0.204 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.178 0.034 CID_108113 | ||
| 0.259 | 0.072 | 0.259 | 5 Hydroxytryptamine uptake stimulant | 0.212 0.129 CID_108113 | ||
| 0.203 | 0.02 | 0.203 | GABA C receptor agonist | 0.202 0.02 CID_108113 | ||
| 0.218 | 0.035 | 0.218 | NOS3 expression enhancer | |||
| 0.239 | 0.056 | 0.241 | RNA-directed DNA polymerase inhibitor | 0.241 0.055 CID_108113 | CID_108113 | |
| 0.187 | 0.005 | 0.187 | Thioredoxin reductase inhibitor | 0.141 0.011 CID_108113 | ||
| 0.186 | 0.004 | 0.186 | Bcl2 antagonist | 0.117 0.01 CID_108113 | ||
| 0.183 | 0.005 | 0.183 | NMDA receptor subunit 3B antagonist | 0.159 0.005 CID_108113 | ||
| 0.199 | 0.023 | 0.199 | Cathepsin H inhibitor | 0.186 0.027 CID_108113 | ||
| 0.179 | 0.003 | 0.179 | Catechol O-methyltransferase inhibitor | 0.082 0.005 CID_108113 | ||
| 0.244 | 0.07 | 0.28 | DNA synthesis inhibitor | 0.28 0.051 CID_108113 | CID_108113 | |
| 0.19 | 0.02 | 0.19 | MAP3K9 inhibitor | 0.16 0.046 CID_108113 | ||
| 0.174 | 0.005 | 0.31 | NMDA 2C receptor antagonist | 0.31 0.004 CID_108113 | CID_108113 | |
| 0.249 | 0.081 | 0.249 | Gastrin inhibitor | 0.182 0.176 CID_108113 | ||
| 0.277 | 0.109 | 0.296 | Transcription factor NF kappa B inhibitor | 0.296 0.096 CID_108113 | CID_108113 | |
| 0.182 | 0.015 | 0.182 | Histidine decarboxylase inhibitor | 0.176 0.016 CID_108113 | ||
| 0.171 | 0.008 | 0.223 | Interleukin 12 antagonist | 0.223 0.005 CID_108113 | CID_108113 | |
| 0.198 | 0.035 | 0.198 | Neurotensin receptor agonist | 0.18 0.05 CID_108113 | ||
| 0.194 | 0.032 | 0.194 | Calcium channel blocker | 0.184 0.037 CID_108113 | ||
| 0.181 | 0.02 | 0.181 | Carbonic anhydrase III inhibitor | 0.178 0.02 CID_108113 | ||
| 0.178 | 0.019 | 0.178 | Photosensitizer | 0.142 0.036 CID_108113 | ||
| 0.243 | 0.085 | 0.243 | Aldehyde oxidase inhibitor | 0.165 0.126 CID_108113 | ||
| 0.175 | 0.018 | 0.175 | TRPA1 agonist | 0.116 0.063 CID_108113 | ||
| 0.175 | 0.021 | 0.2 | Interleukin 8 antagonist | 0.2 0.013 CID_108113 | CID_108113 | |
| 0.159 | 0.005 | 0.201 | AMPA receptor antagonist | 0.201 0.004 CID_108113 | CID_108113 | |
| 0.17 | 0.018 | 0.17 | Beta glucuronidase inhibitor | 0.117 0.048 CID_108113 | ||
| 0.179 | 0.03 | 0.179 | Interleukin 4 antagonist | 0.152 0.048 CID_108113 | ||
| 0.176 | 0.027 | 0.176 | Sphingosine 1-phosphate receptor 5 antagonist | 0.146 0.067 CID_108113 | ||
| 0.158 | 0.009 | 0.158 | Calcium channel L-type blocker | 0.098 0.026 CID_108113 | ||
| 0.15 | 0.003 | 0.15 | Kainate receptor 4 antagonist | 0.079 0.004 CID_108113 | ||
| 0.192 | 0.045 | 0.192 | ATPase inhibitor | 0.139 0.122 CID_108113 | ||
| 0.186 | 0.039 | 0.186 | Alkaline phosphatase inhibitor | 0.14 0.067 CID_108113 | ||
| 0.18 | 0.033 | 0.18 | Aldehyde dehydrogenase inhibitor | 0.133 0.059 CID_108113 | ||
| 0.149 | 0.003 | 0.149 | NMDA 2D receptor antagonist | 0.065 0.005 CID_108113 | ||
| 0.168 | 0.022 | 0.168 | Potassium channel (Ca-activated) activator | 0.161 0.024 CID_108113 | ||
| 0.151 | 0.005 | 0.153 | D-Ala-D-Ala ligase inhibitor | 0.153 0.005 CID_108113 | CID_108113 | |
| 0.161 | 0.018 | 0.161 | Urease inhibitor | 0.134 0.033 CID_108113 | ||
| 0.165 | 0.023 | 0.165 | Catalase inhibitor | 0.088 0.043 CID_108113 | ||
| 0.237 | 0.096 | 0.237 | 5 Hydroxytryptamine release stimulant | 0.184 0.137 CID_108113 | ||
| 0.144 | 0.003 | 0.144 | Kainate receptor 3 antagonist | 0.049 0.004 CID_108113 | ||
| 0.251 | 0.112 | 0.251 | Caspase 3 stimulant | |||
| 0.207 | 0.07 | 0.236 | Neurotrophic factor enhancer | 0.236 0.047 CID_108113 | CID_108113 | |
| 0.142 | 0.004 | 0.142 | AMPA 2 receptor antagonist | 0.086 0.006 CID_108113 | ||
| 0.178 | 0.041 | 0.178 | Cell wall synthesis inhibitor | 0.155 0.061 CID_108113 | ||
| 0.179 | 0.043 | 0.179 | GABA C receptor rho-2 antagonist | 0.179 0.043 CID_108113 | ||
| 0.169 | 0.033 | 0.169 | Cystathionine beta-synthase inhibitor | 0.141 0.045 CID_108113 | ||
| 0.156 | 0.021 | 0.156 | Androgen antagonist | 0.103 0.045 CID_108113 | ||
| 0.152 | 0.018 | 0.152 | Phosphofructokinase-1 inhibitor | 0.127 0.023 CID_108113 | ||
| 0.159 | 0.027 | 0.159 | Protein kinase C gamma inhibitor | 0.139 0.038 CID_108113 | ||
| 0.137 | 0.005 | 0.137 | NMDA receptor subunit 3A antagonist | 0.124 0.006 CID_108113 | ||
| 0.152 | 0.02 | 0.152 | Phosphodiesterase 7B inhibitor | 0.146 0.023 CID_108113 | ||
| 0.163 | 0.033 | 0.163 | Aminopeptidase B inhibitor | 0.144 0.04 CID_108113 | ||
| 0.201 | 0.074 | 0.201 | Death-associated protein kinase 3 inhibitor | 0.187 0.082 CID_108113 | ||
| 0.136 | 0.01 | 0.138 | NMDA receptor agonist | 0.138 0.01 CID_108113 | CID_108113 | |
| 0.144 | 0.018 | 0.183 | NMDA 2 receptor antagonist | 0.183 0.011 CID_108113 | CID_108113 | |
| 0.155 | 0.032 | 0.155 | Ca2+-transporting ATPase inhibitor | 0.141 0.07 CID_108113 | ||
| 0.145 | 0.022 | 0.145 | Potassium channel activator | 0.112 0.038 CID_108113 | ||
| 0.197 | 0.076 | 0.197 | Anesthetic general | 0.182 0.085 CID_108113 | ||
| 0.156 | 0.036 | 0.177 | Alpha 2b adrenoreceptor antagonist | 0.177 0.03 CID_108113 | CID_108113 | |
| 0.128 | 0.009 | 0.128 | Androgen agonist | 0.092 0.018 CID_108113 | ||
| 0.132 | 0.013 | 0.132 | Glycine receptor antagonist | 0.092 0.04 CID_108113 | ||
| 0.165 | 0.046 | 0.165 | NADPH oxidase inhibitor | 0.12 0.083 CID_108113 | ||
| 0.145 | 0.028 | 0.145 | Multidrug resistance-associated protein 1 inhibitor | 0.117 0.052 CID_108113 | ||
| 0.164 | 0.048 | 0.164 | MAP kinase 3 inhibitor | 0.142 0.08 CID_108113 | ||
| 0.14 | 0.024 | 0.14 | Factor V inhibitor | 0.127 0.032 CID_108113 | ||
| 0.12 | 0.006 | 0.129 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.129 0.005 CID_108113 | CID_108113 | |
| 0.156 | 0.042 | 0.156 | Antibacterial (Helicobacter pylori) | |||
| 0.147 | 0.034 | 0.168 | DNA repair enzyme inhibitor | 0.168 0.019 CID_108113 | CID_108113 | |
| 0.168 | 0.056 | 0.168 | Amylase inhibitor | 0.126 0.077 CID_108113 | ||
| 0.14 | 0.028 | 0.14 | Breast cancer-resistant protein inhibitor | 0.091 0.064 CID_108113 | ||
| 0.143 | 0.033 | 0.143 | CC chemokine 6 receptor antagonist | 0.121 0.113 CID_108113 | ||
| 0.125 | 0.014 | 0.125 | Argininosuccinate synthase inhibitor | 0.112 0.016 CID_108113 | ||
| 0.211 | 0.102 | 0.211 | Neuropeptide Y2 antagonist | 0.176 0.169 CID_108113 | ||
| 0.112 | 0.005 | 0.112 | Glutamate (mGluR4) antagonist | 0.098 0.005 CID_108113 | ||
| 0.117 | 0.01 | 0.117 | NMDA receptor glycine site agonist | 0.117 0.01 CID_108113 | ||
| 0.165 | 0.058 | 0.165 | Thiol protease inhibitor | 0.159 0.062 CID_108113 | ||
| 0.11 | 0.005 | 0.128 | Transcription factor RelA inhibitor | 0.128 0.003 CID_108113 | CID_108113 | |
| 0.124 | 0.02 | 0.124 | Glutathione S-transferase inhibitor | 0.084 0.056 CID_108113 | ||
| 0.11 | 0.006 | 0.151 | Kainate receptor antagonist | 0.151 0.005 CID_108113 | CID_108113 | |
| 0.12 | 0.017 | 0.12 | Sphingosine 1-phosphate receptor 4 agonist | 0.094 0.028 CID_108113 | ||
| 0.142 | 0.04 | 0.142 | 5 Hydroxytryptamine 3A agonist | 0.127 0.05 CID_108113 | ||
| 0.168 | 0.068 | 0.168 | Arachidonic acid antagonist | 0.138 0.103 CID_108113 | ||
| 0.122 | 0.022 | 0.122 | Glutamate dehydrogenase inhibitor | 0.109 0.026 CID_108113 | ||
| 0.125 | 0.026 | 0.125 | Lanosterol 14 alpha demethylase inhibitor | 0.108 0.044 CID_108113 | ||
| 0.125 | 0.026 | 0.125 | NADH dehydrogenase inhibitor | 0.114 0.032 CID_108113 | ||
| 0.15 | 0.052 | 0.15 | Pregnane X receptor agonist | |||
| 0.137 | 0.039 | 0.137 | Caspase 3 inhibitor | |||
| 0.108 | 0.012 | 0.108 | GABA B receptor agonist | 0.098 0.018 CID_108113 | ||
| 0.182 | 0.085 | 0.182 | Focal adhesion kinase 2 inhibitor | 0.169 0.102 CID_108113 | ||
| 0.115 | 0.018 | 0.132 | GABA aminotransferase inhibitor | 0.132 0.012 CID_108113 | CID_108113 | |
| 0.117 | 0.022 | 0.117 | Glutamate decarboxylase inhibitor | 0.092 0.034 CID_108113 | ||
| 0.116 | 0.021 | 0.116 | 3C-Like protease (SARS coronavirus) inhibitor | 0.08 0.068 CID_108113 | ||
| 0.118 | 0.023 | 0.122 | Glutamate release inhibitor | 0.122 0.021 CID_108113 | CID_108113 | |
| 0.127 | 0.033 | 0.127 | Anabolic | 0.105 0.056 CID_108113 | ||
| 0.122 | 0.028 | 0.122 | Histamine N-methyltransferase inhibitor | 0.12 0.029 CID_108113 | ||
| 0.098 | 0.004 | 0.119 | Thymidylate synthase inhibitor | 0.119 0.004 CID_108113 | CID_108113 | |
| 0.098 | 0.006 | 0.098 | Calcium channel P-type blocker | 0.084 0.012 CID_108113 | ||
| 0.184 | 0.093 | 0.206 | Interleukin antagonist | 0.206 0.081 CID_108113 | CID_108113 | |
| 0.134 | 0.044 | 0.134 | Calcium channel (voltage-sensitive) blocker | 0.127 0.049 CID_108113 | ||
| 0.17 | 0.08 | 0.251 | LIM domain kinase 1 inhibitor | 0.251 0.037 CID_108113 | CID_108113 | |
| 0.095 | 0.005 | 0.095 | Glutamate (mGluR group III) antagonist | 0.082 0.007 CID_108113 | ||
| 0.159 | 0.07 | 0.159 | Protein-tyrosine phosphatase inhibitor | 0.13 0.102 CID_108113 | ||
| 0.229 | 0.14 | 0.229 | Cholesterol antagonist | |||
| 0.1 | 0.013 | 0.106 | NMDA 2A receptor antagonist | 0.106 0.012 CID_108113 | CID_108113 | |
| 0.13 | 0.043 | 0.144 | GABA C receptor antagonist | 0.144 0.033 CID_108113 | CID_108113 | |
| 0.149 | 0.063 | 0.149 | Cytokine production inhibitor | |||
| 0.124 | 0.037 | 0.141 | GABA C receptor rho-1 antagonist | 0.141 0.026 CID_108113 | CID_108113 | |
| 0.115 | 0.029 | 0.115 | CYP2A6 inhibitor | 0.076 0.052 CID_108113 | ||
| 0.106 | 0.02 | 0.106 | Aromatase inhibitor | 0.081 0.027 CID_108113 | ||
| 0.091 | 0.005 | 0.091 | Kainate receptor 2 antagonist | 0.067 0.009 CID_108113 | ||
| 0.101 | 0.016 | 0.101 | Purinergic P2X1 antagonist | 0.092 0.019 CID_108113 | ||
| 0.128 | 0.044 | 0.128 | Alpha 2c adrenoreceptor antagonist | 0.122 0.048 CID_108113 | ||
| 0.152 | 0.069 | 0.214 | CDC-like kinase 1 inhibitor | 0.214 0.029 CID_108113 | CID_108113 | |
| 0.114 | 0.032 | 0.12 | Carbonic anhydrase XIII inhibitor | 0.12 0.03 CID_108113 | CID_108113 | |
| 0.103 | 0.022 | 0.148 | T cell inhibitor | 0.148 0.01 CID_108113 | CID_108113 | |
| 0.086 | 0.006 | 0.086 | Potassium channel (Inward rectifier) activator | 0.058 0.022 CID_108113 | ||
| 0.123 | 0.044 | 0.146 | Carbonic anhydrase XV inhibitor | 0.146 0.032 CID_108113 | CID_108113 | |
| 0.096 | 0.017 | 0.096 | Glutamate (mGluR1) antagonist | 0.084 0.021 CID_108113 | ||
| 0.083 | 0.006 | 0.083 | Potassium channel (ATP-sensitive) activator | 0.056 0.021 CID_108113 | ||
| 0.083 | 0.006 | 0.083 | AMPA 4 receptor antagonist | 0.079 0.006 CID_108113 | ||
| 0.214 | 0.137 | 0.214 | Insulysin inhibitor | |||
| 0.105 | 0.029 | 0.105 | Granulocyte macrophage colony stimulating factor agonist | 0.103 0.031 CID_108113 | ||
| 0.137 | 0.061 | 0.137 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.079 | 0.004 | 0.079 | Nerve growth factor antagonist | 0.069 0.005 CID_108113 | ||
| 0.143 | 0.068 | 0.143 | Histone deacetylase SIRT1 inhibitor | 0.113 0.1 CID_108113 | ||
| 0.171 | 0.098 | 0.184 | I kappa B kinase epsilon inhibitor | 0.184 0.085 CID_108113 | CID_108113 | |
| 0.16 | 0.088 | 0.164 | Phospholipase C inhibitor | 0.164 0.081 CID_108113 | CID_108113 | |
| 0.077 | 0.007 | 0.077 | GABA B receptor antagonist | 0.075 0.007 CID_108113 | ||
| 0.092 | 0.022 | 0.092 | Carbonic anhydrase IX inhibitor | 0.089 0.023 CID_108113 | ||
| 0.078 | 0.008 | 0.103 | AICAR transformylase inhibitor | 0.103 0.005 CID_108113 | CID_108113 | |
| 0.073 | 0.004 | 0.077 | Glutamate (mGluR8) agonist | 0.077 0.004 CID_108113 | CID_108113 | |
| 0.084 | 0.015 | 0.094 | Botulinum neurotoxin type A inhibitor | 0.094 0.011 CID_108113 | CID_108113 | |
| 0.085 | 0.016 | 0.085 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.067 0.032 CID_108113 | ||
| 0.128 | 0.061 | 0.128 | Topoisomerase II inhibitor | 0.111 0.075 CID_108113 | ||
| 0.078 | 0.011 | 0.078 | Dihydroorotate oxidase inhibitor | 0.063 0.024 CID_108113 | ||
| 0.081 | 0.015 | 0.081 | Plasminogen activator inhibitor antagonist | 0.05 0.032 CID_108113 | ||
| 0.221 | 0.155 | 0.221 | Apoptosis antagonist | |||
| 0.14 | 0.074 | 0.14 | Heat shock protein 70 antagonist | |||
| 0.089 | 0.022 | 0.089 | Carbonic anhydrase XII inhibitor | 0.083 0.024 CID_108113 | ||
| 0.085 | 0.02 | 0.085 | Caspase 9 inhibitor | 0.069 0.033 CID_108113 | ||
| 0.082 | 0.016 | 0.082 | Potassium channel intermediate-conductance Ca-activated blocker | 0.056 0.051 CID_108113 | ||
| 0.092 | 0.029 | 0.092 | Carbonic anhydrase VA inhibitor | 0.085 0.033 CID_108113 | ||
| 0.133 | 0.07 | 0.133 | Nav1.2 sodium channel blocker | 0.108 0.099 CID_108113 | ||
| 0.111 | 0.048 | 0.111 | Sphingomyelinase inhibitor | |||
| 0.067 | 0.005 | 0.067 | Kainate receptor agonist | 0.057 0.008 CID_108113 | ||
| 0.083 | 0.021 | 0.083 | Exportin-1 inhibitor | 0.079 0.027 CID_108113 | ||
| 0.1 | 0.039 | 0.111 | Carbonic anhydrase VI inhibitor | 0.111 0.033 CID_108113 | CID_108113 | |
| 0.089 | 0.027 | 0.089 | Vanilloid 4 agonist | |||
| 0.212 | 0.151 | 0.212 | Thyroid hormone antagonist | |||
| 0.091 | 0.03 | 0.091 | Carbonic anhydrase inhibitor | 0.083 0.034 CID_108113 | ||
| 0.092 | 0.031 | 0.092 | Prostaglandin-E synthase inhibitor | |||
| 0.073 | 0.013 | 0.073 | Lysophosphatidic acid 3 receptor antagonist | 0.058 0.025 CID_108113 | ||
| 0.097 | 0.037 | 0.097 | Histamine H2 receptor antagonist | 0.094 0.042 CID_108113 | ||
| 0.065 | 0.005 | 0.065 | Phenylethanolamine N methyltransferase inhibitor | 0.052 0.012 CID_108113 | ||
| 0.188 | 0.128 | 0.188 | Immunostimulant | 0.174 0.136 CID_108113 | ||
| 0.073 | 0.014 | 0.073 | Ryanodine receptor antagonist | 0.068 0.02 CID_108113 | ||
| 0.119 | 0.061 | 0.119 | Transcription factor STAT6 inhibitor | |||
| 0.082 | 0.024 | 0.082 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.062 0.038 CID_108113 | ||
| 0.066 | 0.008 | 0.066 | Alpha 1d adrenoreceptor agonist | 0.038 0.027 CID_108113 | ||
| 0.153 | 0.097 | 0.192 | Tumour necrosis factor antagonist | 0.192 0.058 CID_108113 | CID_108113 | |
| 0.072 | 0.016 | 0.072 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.072 | 0.017 | 0.072 | Bcl-xL inhibitor | |||
| 0.078 | 0.023 | 0.078 | MDM2 inhibitor | 0.066 0.051 CID_108113 | ||
| 0.061 | 0.007 | 0.075 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.075 0.005 CID_108113 | CID_108113 | |
| 0.068 | 0.013 | 0.075 | Fructose-1,6-bisphosphatase inhibitor | 0.075 0.01 CID_108113 | CID_108113 | |
| 0.063 | 0.009 | 0.063 | AMPA 1 receptor antagonist | 0.05 0.011 CID_108113 | ||
| 0.087 | 0.032 | 0.087 | Carbonic anhydrase V inhibitor | 0.079 0.036 CID_108113 | ||
| 0.072 | 0.018 | 0.072 | Aconitate hydratase inhibitor | 0.051 0.037 CID_108113 | ||
| 0.068 | 0.015 | 0.068 | Aldosterone antagonist | |||
| 0.076 | 0.023 | 0.076 | Ornithine carbamoyltransferase inhibitor | 0.071 0.025 CID_108113 | ||
| 0.138 | 0.085 | 0.138 | Neuropeptide Y1 antagonist | 0.126 0.108 CID_108113 | ||
| 0.059 | 0.006 | 0.059 | AMPA 3 receptor antagonist | 0.054 0.008 CID_108113 | ||
| 0.196 | 0.144 | 0.196 | Lipoxygenase inhibitor | 0.175 0.17 CID_108113 | ||
| 0.143 | 0.091 | 0.143 | Melanin inhibitor | |||
| 0.059 | 0.007 | 0.059 | Integrin alpha2 antagonist | 0.052 0.01 CID_108113 | ||
| 0.086 | 0.035 | 0.086 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.059 | 0.009 | 0.059 | Potassium channel Kv1.1 blocker | 0.04 0.024 CID_108113 | ||
| 0.077 | 0.026 | 0.077 | Carbonic anhydrase I inhibitor | 0.064 0.032 CID_108113 | ||
| 0.073 | 0.024 | 0.073 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.064 0.03 CID_108113 | ||
| 0.076 | 0.026 | 0.076 | Nitric oxide donor | |||
| 0.119 | 0.07 | 0.119 | Histone deacetylase class III inhibitor | 0.1 0.09 CID_108113 | ||
| 0.201 | 0.153 | 0.201 | Thyroid hormone beta antagonist | |||
| 0.104 | 0.057 | 0.104 | Xanthine oxidase inhibitor | |||
| 0.202 | 0.155 | 0.202 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.195 0.163 CID_108113 | ||
| 0.052 | 0.005 | 0.052 | NMDA receptor glycine site antagonist | 0.044 0.007 CID_108113 | ||
| 0.074 | 0.027 | 0.074 | Carbonic anhydrase II inhibitor | 0.064 0.032 CID_108113 | ||
| 0.111 | 0.064 | 0.119 | Acetylcholine release stimulant | 0.119 0.049 CID_108113 | CID_108113 | |
| 0.089 | 0.042 | 0.089 | Na+ K+ transporting ATPase inhibitor | 0.067 0.062 CID_108113 | ||
| 0.138 | 0.092 | 0.138 | Cyclin-dependent kinase 8 inhibitor | 0.136 0.094 CID_108113 | ||
| 0.067 | 0.021 | 0.067 | Carbonic anhydrase XIV inhibitor | 0.066 0.022 CID_108113 | ||
| 0.065 | 0.021 | 0.065 | Alpha-mannosidase inhibitor | 0.057 0.031 CID_108113 | ||
| 0.081 | 0.037 | 0.081 | Phenylalanine 4-hydroxylase inhibitor | 0.074 0.043 CID_108113 | ||
| 0.079 | 0.036 | 0.079 | Potassium channel large-conductance Ca-activated activator | 0.071 0.043 CID_108113 | ||
| 0.069 | 0.026 | 0.069 | Fatty acid synthase inhibitor | |||
| 0.048 | 0.005 | 0.048 | Kainate receptor 1 antagonist | 0.027 0.012 CID_108113 | ||
| 0.073 | 0.032 | 0.073 | Carbamoyl phosphate synthetase inhibitor | 0.068 0.036 CID_108113 | ||
| 0.097 | 0.056 | 0.097 | Bile acid receptor antagonist | |||
| 0.062 | 0.022 | 0.062 | Potassium channel (Inward rectifier) blocker | |||
| 0.086 | 0.047 | 0.086 | Phosphodiesterase 3A inhibitor | 0.076 0.062 CID_108113 | ||
| 0.105 | 0.066 | 0.105 | Topoisomerase I inhibitor | 0.094 0.075 CID_108113 | ||
| 0.075 | 0.035 | 0.075 | Glutamate (mGluR7) antagonist | |||
| 0.102 | 0.062 | 0.108 | Protein kinase (CK2) inhibitor | 0.108 0.057 CID_108113 | CID_108113 | |
| 0.057 | 0.017 | 0.057 | Purinergic P2X4 antagonist | |||
| 0.118 | 0.079 | 0.118 | Cyclooxygenase 3 inhibitor | |||
| 0.133 | 0.095 | 0.133 | Adenylate cyclase stimulant | 0.126 0.11 CID_108113 | ||
| 0.057 | 0.019 | 0.057 | Collagenase inhibitor | 0.046 0.043 CID_108113 | ||
| 0.155 | 0.117 | 0.174 | MAP kinase kinase 2 inhibitor | 0.174 0.101 CID_108113 | CID_108113 | |
| 0.05 | 0.013 | 0.05 | Heme oxygenase inhibitor | 0.042 0.032 CID_108113 | ||
| 0.067 | 0.029 | 0.067 | Carbonic anhydrase VB inhibitor | 0.067 0.03 CID_108113 | ||
| 0.052 | 0.014 | 0.052 | GABA uptake inhibitor | |||
| 0.058 | 0.02 | 0.058 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.074 | 0.037 | 0.074 | HIV-1 integrase (3'-Processing) inhibitor | |||
| 0.136 | 0.099 | 0.136 | Interferon gamma antagonist | |||
| 0.149 | 0.113 | 0.149 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.145 0.117 CID_108113 | ||
| 0.058 | 0.022 | 0.086 | Sodium/calcium exchanger inhibitor | 0.086 0.007 CID_108113 | CID_108113 | |
| 0.051 | 0.016 | 0.067 | Dihydropteroate synthase inhibitor | 0.067 0.009 CID_108113 | CID_108113 | |
| 0.06 | 0.025 | 0.06 | Immunoglobulin Fc receptor antagonist | 0.058 0.03 CID_108113 | ||
| 0.049 | 0.015 | 0.058 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.058 0.009 CID_108113 | CID_108113 | |
| 0.07 | 0.036 | 0.07 | HIV-1 integrase (Strand Transfer) inhibitor | |||
| 0.054 | 0.021 | 0.054 | Mannosidase inhibitor | 0.046 0.03 CID_108113 | ||
| 0.124 | 0.09 | 0.124 | Nav1.6 sodium channel blocker | |||
| 0.053 | 0.021 | 0.053 | Benzodiazepine antagonist | |||
| 0.07 | 0.039 | 0.07 | Glutamate (mGluR6) antagonist | 0.07 0.039 CID_108113 | ||
| 0.038 | 0.007 | 0.038 | Integrin alpha2beta1 antagonist | 0.034 0.009 CID_108113 | ||
| 0.06 | 0.029 | 0.06 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.116 | 0.084 | 0.116 | Cyclooxygenase 2 inhibitor | |||
| 0.062 | 0.032 | 0.062 | Acyl-CoA dehydrogenase inhibitor | 0.053 0.04 CID_108113 | ||
| 0.066 | 0.036 | 0.066 | Alpha 2 adrenoreceptor agonist | 0.056 0.048 CID_108113 | ||
| 0.096 | 0.066 | 0.139 | Nitric-oxide synthase inhibitor | 0.139 0.028 CID_108113 | CID_108113 | |
| 0.035 | 0.006 | 0.035 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.034 | 0.005 | 0.037 | Complement factor 1s inhibitor | 0.037 0.004 CID_108113 | CID_108113 | |
| 0.049 | 0.02 | 0.066 | Dihydrofolate reductase inhibitor | 0.066 0.008 CID_108113 | CID_108113 | |
| 0.078 | 0.05 | 0.087 | Alpha 2a adrenoreceptor antagonist | 0.087 0.043 CID_108113 | CID_108113 | |
| 0.153 | 0.126 | 0.153 | Anticonvulsant | 0.148 0.131 CID_108113 | ||
| 0.064 | 0.037 | 0.079 | Prolactin release inhibitor | 0.079 0.012 CID_108113 | CID_108113 | |
| 0.052 | 0.026 | 0.052 | Oleamide hydrolase inhibitor | |||
| 0.055 | 0.03 | 0.055 | Phosphodiesterase 7A inhibitor | 0.052 0.036 CID_108113 | ||
| 0.045 | 0.02 | 0.045 | Progesterone antagonist | |||
| 0.078 | 0.054 | 0.078 | Topoisomerase II alpha inhibitor | |||
| 0.058 | 0.034 | 0.058 | Glucosylceramidase inhibitor | |||
| 0.041 | 0.018 | 0.041 | Fumarate hydratase inhibitor | 0.033 0.025 CID_108113 | ||
| 0.03 | 0.008 | 0.035 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.035 0.005 CID_108113 | CID_108113 | |
| 0.076 | 0.054 | 0.076 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.077 | 0.055 | 0.077 | Macrophage migration inhibitory factor inhibitor | |||
| 0.081 | 0.06 | 0.081 | CC chemokine 5 receptor agonist | |||
| 0.069 | 0.049 | 0.069 | Protein kinase C beta inhibitor | |||
| 0.03 | 0.009 | 0.03 | Acid ceramidase inhibitor | |||
| 0.073 | 0.053 | 0.073 | Adenosine A3 receptor antagonist | 0.067 0.065 CID_108113 | ||
| 0.071 | 0.051 | 0.24 | Telomerase inhibitor | 0.24 0.01 CID_108113 | CID_108113 | |
| 0.032 | 0.012 | 0.032 | Estrogen-related receptor gamma antagonist | 0.028 0.021 CID_108113 | ||
| 0.046 | 0.026 | 0.046 | Glutamate (mGluR group III) agonist | 0.041 0.032 CID_108113 | ||
| 0.085 | 0.066 | 0.117 | Pim-3 kinase inhibitor | 0.117 0.033 CID_108113 | CID_108113 | |
| 0.095 | 0.077 | 0.095 | AMP-activated protein kinase stimulant | |||
| 0.023 | 0.004 | 0.023 | Thromboxane A2 agonist | 0.014 0.013 CID_108113 | ||
| 0.035 | 0.017 | 0.035 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.022 | 0.004 | 0.022 | Human herpes virus 5 capsid protein P40 inhibitor | 0.012 0.011 CID_108113 | ||
| 0.037 | 0.019 | 0.037 | Glutamate (mGluR4) agonist | 0.034 0.023 CID_108113 | ||
| 0.062 | 0.044 | 0.062 | Histone deacetylase SIRT3 inhibitor | |||
| 0.024 | 0.007 | 0.024 | Alpha 2a adrenoreceptor agonist | |||
| 0.031 | 0.014 | 0.031 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.034 | 0.017 | 0.034 | Epoxide hydrolase 1 inhibitor | |||
| 0.04 | 0.024 | 0.04 | TRPM8 blocker | |||
| 0.041 | 0.026 | 0.041 | Dopamine D5 agonist | 0.037 0.032 CID_108113 | ||
| 0.024 | 0.009 | 0.024 | Factor XIII inhibitor | 0.021 0.013 CID_108113 | ||
| 0.035 | 0.021 | 0.041 | Purinergic P2Y2 antagonist | 0.041 0.015 CID_108113 | CID_108113 | |
| 0.065 | 0.05 | 0.065 | Cyclin B3 inhibitor | |||
| 0.074 | 0.06 | 0.074 | Estrogen receptor alpha antagonist | |||
| 0.08 | 0.066 | 0.08 | Estrogen-related receptor beta agonist | |||
| 0.028 | 0.014 | 0.028 | Thymidine phosphorylase inhibitor | 0.025 0.021 CID_108113 | ||
| 0.053 | 0.04 | 0.053 | Thromboxane synthase inhibitor | |||
| 0.033 | 0.02 | 0.033 | Estrogen-related receptor beta antagonist | |||
| 0.092 | 0.079 | 0.092 | Falcipain 3 inhibitor | |||
| 0.113 | 0.1 | 0.113 | Protein kinase stimulant | |||
| 0.068 | 0.056 | 0.068 | Aminopeptidase I inhibitor | |||
| 0.038 | 0.025 | 0.038 | Factor XIIIa inhibitor | |||
| 0.101 | 0.089 | 0.101 | Microtubule formation inhibitor | |||
| 0.021 | 0.008 | 0.021 | Potassium channel (Inward rectifier) 11 blocker | |||
| 0.023 | 0.011 | 0.023 | Imidazoline I1 receptor antagonist | |||
| 0.045 | 0.034 | 0.045 | Carbonic anhydrase VII inhibitor | |||
| 0.026 | 0.014 | 0.026 | Glutamate (mGluR1) agonist | |||
| 0.061 | 0.05 | 0.061 | Neutrophil collagenase inhibitor | |||
| 0.023 | 0.012 | 0.023 | Glutaminyl-peptide cyclotransferase inhibitor | |||
| 0.053 | 0.042 | 0.053 | DNA helicase inhibitor | |||
| 0.162 | 0.152 | 0.162 | Spasmolytic | |||
| 0.016 | 0.005 | 0.016 | Glutamate (mGluR6) agonist | 0.015 0.005 CID_108113 | ||
| 0.041 | 0.031 | 0.041 | Angiotensin AT1 receptor antagonist | |||
| 0.022 | 0.012 | 0.022 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.105 | 0.096 | 0.154 | Acetylcholinesterase inhibitor | 0.154 0.053 CID_108113 | CID_108113 | |
| 0.027 | 0.018 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.113 | 0.105 | 0.113 | Activin receptor-like kinase 2 inhibitor | |||
| 0.067 | 0.059 | 0.067 | Phospholipase D inhibitor | |||
| 0.041 | 0.033 | 0.041 | Histamine H2 receptor agonist | 0.039 0.035 CID_108113 | ||
| 0.026 | 0.018 | 0.026 | Complement factor 1r inhibitor | |||
| 0.025 | 0.018 | 0.025 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.086 | 0.079 | 0.086 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.012 | 0.005 | 0.012 | Progesterone receptor A antagonist | |||
| 0.114 | 0.107 | 0.114 | Cyclooxygenase inhibitor | |||
| 0.092 | 0.085 | 0.092 | Toll-Like receptor 4 antagonist | |||
| 0.092 | 0.085 | 0.106 | Protein kinase (CK2) alpha inhibitor | 0.106 0.072 CID_108113 | CID_108113 | |
| 0.034 | 0.027 | 0.034 | Adenosine uptake inhibitor | |||
| 0.057 | 0.05 | 0.057 | Phosphodiesterase VII inhibitor | |||
| 0.04 | 0.033 | 0.04 | Carbonic anhydrase IV inhibitor | |||
| 0.02 | 0.013 | 0.02 | Progesterone receptor B antagonist | |||
| 0.084 | 0.078 | 0.105 | Protein kinase C zeta inhibitor | 0.105 0.045 CID_108113 | CID_108113 | |
| 0.027 | 0.022 | 0.03 | CDK4/cyclin D3 inhibitor | 0.03 0.018 CID_108113 | CID_108113 | |
| 0.013 | 0.008 | 0.013 | Carbonic anhydrase XI inhibitor | |||
| 0.029 | 0.024 | 0.031 | Endothelial nitric-oxide synthase inhibitor | 0.031 0.021 CID_108113 | CID_108113 | |
| 0.051 | 0.045 | 0.051 | Xanthine dehydrogenase inhibitor | |||
| 0.086 | 0.081 | 0.086 | Electrolyte absorption antagonist | |||
| 0.082 | 0.078 | 0.082 | Prolactin inhibitor | |||
| 0.022 | 0.018 | 0.022 | ICAM 1 antagonist | |||
| 0.026 | 0.022 | 0.026 | Uridine phosphorylase inhibitor | |||
| 0.016 | 0.012 | 0.017 | CDK2/cyclin A3 inhibitor | 0.017 0.009 CID_108113 | CID_108113 | |
| 0.031 | 0.028 | 0.031 | Free fatty acid receptor 1 antagonist | |||
| 0.046 | 0.042 | 0.046 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.064 | 0.06 | 0.064 | Macrophage colony-stimulating factor 1 receptor antagonist | |||
| 0.031 | 0.028 | 0.031 | RNA-directed RNA polymerase inhibitor | |||
| 0.056 | 0.053 | 0.056 | Phosphodiesterase 1A inhibitor | |||
| 0.045 | 0.043 | 0.045 | Aldose reductase inhibitor | |||
| 0.048 | 0.046 | 0.048 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.057 | 0.055 | 0.071 | CDC25B inhibitor | 0.071 0.037 CID_108113 | CID_108113 | |
| 0.053 | 0.052 | 0.053 | Pregnane X receptor antagonist | |||
| 0.026 | 0.025 | 0.026 | Purinergic P2Y15 antagonist | |||
| 0.026 | 0.025 | 0.026 | 5 Hydroxytryptamine 6 agonist | |||
| 0.03 | 0.029 | 0.03 | Calcium release-activated channel blocker | |||
| 0.014 | 0.014 | 0.014 | Purinergic P2Y1 agonist | 0.014 0.013 CID_108113 | CID_108113 | |
| 0.031 | 0.032 | 0.041 | 5 Hydroxytryptamine 3B antagonist | 0.041 0.02 CID_108113 | CID_108113 | |
| 0.091 | 0.093 | 0.119 | Anesthetic local | 0.119 0.067 CID_108113 | CID_108113 | |
| 0.055 | 0.058 | 0.071 | I kappa B kinase 2 inhibitor | 0.071 0.031 CID_108113 | CID_108113 | |
| 0.224 | 0.227 | 0.268 | MAP kinase kinase 6 inhibitor | 0.268 0.169 CID_108113 | CID_108113 | |
| 0.205 | 0.208 | 0.244 | 15-Lipoxygenase inhibitor | 0.244 0.169 CID_108113 | CID_108113 | |
| 0.08 | 0.092 | 0.091 | Cyclin-dependent kinase 9 inhibitor | 0.091 0.073 CID_108113 | CID_108113 | |
| 0.042 | 0.061 | 0.058 | 5 Hydroxytryptamine 3 antagonist | 0.058 0.037 CID_108113 | CID_108113 | |
| 0.063 | 0.094 | 0.082 | I kappa B kinase inhibitor | 0.082 0.058 CID_108113 | CID_108113 | |
| 0.033 | 0.065 | 0.041 | Potassium channel small-conductance Ca-activated blocker | 0.041 0.038 CID_108113 | CID_108113 | |
| 0.063 | 0.098 | 0.089 | Inducible nitric-oxide synthase inhibitor | 0.089 0.049 CID_108113 | CID_108113 | |
| 0.028 | 0.088 | 0.05 | Adenosine A1 receptor antagonist | 0.05 0.049 CID_108113 | CID_108113 | |
| 0.078 | 0.144 | 0.164 | Ribosomal protein S6 kinase inhibitor | 0.164 0.055 CID_108113 | CID_108113 | |
| 0.041 | 0.106 | 0.054 | Heat shock protein 90 beta antagonist | 0.054 0.052 CID_108113 | CID_108113 | |
| 0.01 | 0.082 | 0.047 | Poly(ADP-ribose) polymerase 2 inhibitor | 0.047 0.009 CID_108113 | CID_108113 | |
| 0.09 | 0.184 | 0.182 | Clk dual-specificity kinase inhibitor | 0.182 0.09 CID_108113 | CID_108113 | |
| 0.095 | 0.245 | 0.223 | Tumour necrosis factor alpha release inhibitor | 0.223 0.09 CID_108113 | CID_108113 | |
| 0.041 | 0.205 | 0.083 | MAP kinase 9 inhibitor | 0.083 0.079 CID_108113 | CID_108113 | |
| 0.129 | 0.441 | 0.252 | MAP kinase kinase 3 inhibitor | 0.252 0.03 CID_108113 | CID_108113 | |
| 0.023 | 0.385 | 0.05 | Alpha 1b adrenoreceptor agonist | 0.05 0.036 CID_108113 | CID_108113 | |
| 0.062 | 0.483 | 0.155 | Lipocortins synthesis antagonist | 0.155 0.098 CID_108113 | CID_108113 | |
| 0.014 | 0.483 | 0.075 | Potassium channel (Ca-activated) blocker | 0.075 0.022 CID_108113 | CID_108113 | |
| 0.03 | 0.591 | 0.09 | Toll-Like receptor 3 antagonist | 0.09 0.069 CID_108113 | CID_108113 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |